Robuta

https://www.biospace.com/press-releases/tilt-biotherapeutics-announces-closing-of-usd-25-million-series-b-financing TILT Biotherapeutics Announces Closing of USD 25 Million Series B Financing - BioSpace series b financing https://www.dlapiper.com/en-us/news/2020/09/dla-piper-advises-bessemer-venture-partners-in-series-b-financing-of-alloy DLA Piper advises Bessemer Venture Partners in Series B financing of Alloy | DLA Piper DLA Piper advised Bessemer Venture Partners in the Series B financing of Alloy. bessemer venture partnersdla piper https://www.prnewswire.com/news-releases/spiral-therapeutics-announces-27-million-series-b-financing-and-strategic-partnership-with-advanced-bionics-302741713.html Spiral Therapeutics Announces $27 Million Series B Financing and Strategic Partnership with... Advanced Bionics and a major global pharmaceutical company join Spiral's Series B financing as new strategic investors, with Gund Investment leading the... series b financing27 million https://www.businesswire.com/news/home/20250325176219/en/Evident-Vascular-Raises-Series-B-Financing-to-Advance-AI-Powered-Intravascular-Ultrasound-Platform-Technology Evident Vascular Raises Series B Financing to Advance AI-Powered Intravascular Ultrasound Platform... Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence, ... series b financing https://www.biospace.com/omniome-completes-60-million-series-b-financing-to-advance-novel-genomic-sequencing-technology Omniome Completes $60 Million Series B Financing To Advance Novel Genomic Sequencing Technology -... Jul 30, 2018 - Proceeds to fund further development of breakthrough DNA sequencing platform series b financing https://www.biospace.com/abcuro-announces-155-million-oversubscribed-series-b-financing-to-further-advance-autoimmune-pipeline Abcuro Announces $155 Million Oversubscribed Series B Financing to Further Advance Autoimmune... Sep 26, 2025 - Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of... series b financing https://www.biospace.com/visura-announces-closing-of-series-b-financing Visura Announces Closing of Series B Financing - BioSpace Jan 18, 2023 - Visura Technologies, Inc. announced today the completion of the company's $4 million Series B financing. series b financingvisuraannouncesclosing https://www.fiercebiotech.com/biotech/dnatrix-completes-20-million-series-b-financing DNAtrix Completes $20 Million Series B Financing | Fierce Biotech Oct 15, 2014 - SAN DIEGO -- DNAtrix, a clinical-stage oncolytic immunotherapy company, announced that it has completed a $20M Series B equity financing. New investor... series b financing20 millioncompletesfiercebiotech https://www.businesswire.com/news/home/20241217939392/en/Slip-Robotics-Raises-%2428M-Series-B-Financing-Led-by-DCVC Slip Robotics Raises $28M Series B Financing Led by DCVC Slip Robotics, a next-generation provider of automated truck-loading robots-as-a-service, has raised a $28 million Series B financing led by DCVC, a leading ... series b financingsliproboticsraises28m https://www.newswire.com/news/onclave-secures-10-million-series-b-financing-round-to-secure-critical-21170131 Onclave Secures Series B Financing Round to Secure Critical Infrastructure and 5G Wireless... Led by Pendrell Corporation and Option3Ventures, the latest investment round advances Onclave's mission of delivering innovative cybersecurity communications... series b financing https://www.biospace.com/metagenomi-closes-oversubscribed-series-b-financing-totaling-275m-to-advance-lead-therapeutic-programs-into-clinical-development-and-grow-genetic-medicines-pipeline Metagenomi Closes Oversubscribed Series B Financing Totaling $275M to Advance Lead Therapeutic... Jan 5, 2023 - Metagenomi, a genetic medicines company with a versatile portfolio of wholly owned, next-generation gene editing systems, today announced the close of a Series... series b financing https://www.businesswire.com/news/home/20210811005170/en/Mahana-Therapeutics-Secures-%2461-Million-Series-B-Financing-to-Support-Commercialization-and-Further-Development-of-Digital-Therapeutics Mahana Therapeutics Secures $61 Million Series B Financing to Support Commercialization and Further... Mahana Therapeutics, a leading developer of prescription digital therapeutics designed to empower patients with chronic health conditions, has completed a $6... series b financing https://www.businesswire.com/news/home/20220427005357/en/Concert-Health-Raises-%2442M-Series-B-Financing-to-Scale-Quality-Behavioral-Health-Services-Nationwide Concert Health Raises $42M Series B Financing to Scale Quality Behavioral Health Services Nationwide Concert Health raises $42M Series B financing to scale quality behavioral health services nationwide series b financing https://www.fiercebiotech.com/biotech/navitor-pharmaceuticals-announces-33-million-series-b-financing Navitor Pharmaceuticals Announces $33 Million Series B Financing | Fierce Biotech Dec 18, 2015 - Navitor Pharmaceuticals Announces $33 Million Series B Financing Proceeds Will Accelerate Advancement of Lead mTORC1 Modulator Program Into Clinical Evaluation... series b financingpharmaceuticalsannounces33million https://www.freightwaves.com/news/technology-european-digital-freight-marketplace-sennder-raises-series-b-financing European digital freight marketplace sennder raises Series B financing - FreightWaves Apr 9, 2019 - sennder has raised investment to expand its digital freight markeplace footprint across Europe. series b financingeuropeandigitalfreightmarketplace https://www.businesswire.com/news/home/20200427005818/en/Avalyn-Pharma-Secures-%2435.5-Million-Series-B-Financing-Broadens-Development-Portfolio Avalyn Pharma Secures $35.5 Million Series B Financing, Broadens Development Portfolio Avalyn Pharma Inc., a biopharmaceutical company focused on development of improved therapies for life threatening pulmonary diseases, today announced the com... series b financing35 5 https://www.prnewswire.com/news-releases/planted-closes-series-b-financing-round-of-chf-70-million-301616665.html Planted Closes Series B Financing Round of CHF 70 Million /PRNewswire/ -- Swiss Foodtech Startup Planted, known for its clean-label biostructured meat, successfully closed its series B financing round of CHF 70... series b financingplantedclosesroundchf https://www.biospace.com/b-pharmathene-b-closes-50-million-in-series-b-financing PharmAthene Closes $50 Million In Series B Financing - BioSpace series b financingcloses50million https://www.businesswire.com/news/home/20260313133638/en/Crossbow-Therapeutics-Raises-%2477-Million-in-Series-B-Financing-to-Advance-Development-of-TCR-mimetic-Antibody-Therapies-to-Treat-Cancer Crossbow Therapeutics Raises $77 Million in Series B Financing to Advance Development of... Crossbow announced it raised $77 million in a Series B financing that will advance the development of TCR-mimetic antibody therapies to treat cancer. series b financing https://www.globenewswire.com/news-release/2022/11/14/2554926/0/en/MBX-Biosciences-Closes-115-Million-Series-B-Financing-to-Advance-Development-of-Endocrine-Disease-Programs.html MBX Biosciences Closes $115 Million Series B Financing to Financing led by Wellington Management with participation from other leading healthcare funds... series b financingmbxbiosciencescloses115 https://www.businesswire.com/news/home/20241104363939/en/Inquis-Medical-Announces-%2440-Million-Series-B-Financing-to-Accelerate-Advancement-of-Aventus-Thrombectomy-System-Addressing-Venus-Thromboembolic-Diseases Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus... Inquis Medical closed a $40 million Series B financing to accelerate advancement of its Aventus Thrombectomy System. series b financing https://www.globenewswire.com/news-release/2024/05/09/2879009/0/en/R3-Vascular-Announces-87-Million-in-Series-B-Financing-and-Appoints-Christopher-M-Owens-as-new-President-and-CEO.html R3 Vascular Announces $87 Million in Series B Financing and R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer... series b financingr3vascularannounces87 https://www.biospace.com/intercept-pharmaceuticals-raises-25-million-series-b-financing-b-dr-lorenzo-tallarigo-b-assumes-role-of-chairman Intercept Pharmaceuticals Raises $25 Million Series B Financing; Dr. Lorenzo Tallarigo Assumes Role... series b financing https://matterport.com/fr/news/matterport-raises-16-million-series-b-financing-lead-3d-expansion Matterport Raises $16 Million in Series B Financing to Lead 3D Expansion | Matterport series b financing https://matterport.com/ko/news/matterport-raises-16-million-series-b-financing-lead-3d-expansion Matterport Raises $16 Million in Series B Financing to Lead 3D Expansion | Matterport series b financing https://www.businesswire.com/news/home/20251022627536/en/VitriVax-Raises-%2417.25-Million-Series-B-Financing-to-Advance-Vaccine-Formulation-Platform VitriVax Raises $17.25 Million Series B Financing to Advance Vaccine Formulation Platform VitriVax, Inc., a vaccine formulation technology company, today announced it raised a total of $17.25 million in Series B financing. The round was co-led by ... series b financing https://www.pfizer.com/news/press-release/press-release-detail/cortexyme-completes-76-million-series-b-financing-and Cortexyme Completes $76 Million Series B Financing and Provides Update on Clinical Development... SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc., a clinical-stage pharmaceutical company developing therapeutics to alter the course of... series b financing https://www.biospace.com/grit-biotechnology-announces-closing-of-60-million-series-b-financing Grit Biotechnology Announces Closing of $60 Million Series B Financing - BioSpace Sep 8, 2023 - Grit Biotechnology announced the completion of a Series B financing round, raising over 60 million USD. series b financinggritbiotechnologyannouncesclosing https://www.edsurge.com/news/2017-09-06-guild-education-raises-21-million-in-a-series-b-financing-round Guild Education Raises $21 Million in a Series B Financing Round | EdSurge News Dec 27, 2018 - GUILD EDUCATION: Denver-based education benefits company Guild Education has raised $21 million in a Series B financing round led by Bessemer Ventures. ... series b financing https://matterport.com/es/news/matterport-raises-16-million-series-b-financing-lead-3d-expansion Matterport Raises $16 Million in Series B Financing to Lead 3D Expansion | Matterport series b financing https://www.biospace.com/physiq-snags-8-million-in-series-b-financing physIQ Snags $8 Million in Series B Financing - BioSpace series b financingphysiqsnags8million https://cvffund.com/en CVF Fund — Specialised financing for Series A/B SaaS startups Non-dilutive financing for Series A/B SaaS startups. Structured CAC loans, EBITCAC framework, up to 5-year terms. EU regulated. for seriesa bcvffundspecialised https://www.basf.com/global/en/who-we-are/organization/group-companies/BASF_Venture-Capital/publications/2020/zapata-computing Zapata Computing Announces $38 Million Funding for Series B Financing to Accelerate the Commercial... Funding will enable Zapata to scale research and product development in support of quantum readiness across industries https://www.biospace.com/press-releases/actio-biosciences-secures-66-million-series-b-financing-to-advance-genetics-driven-pipeline-of-small-molecule-therapeutics-for-rare-and-common-diseases Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven Pipeline of... https://www.businesswire.com/news/home/20210608005436/en/Strateos-Closes-%2456-Million-Series-B-Financing-to-Accelerate-the-Roll-Out-of-its-SmartLab-of-the-Future-Platform Strateos Closes $56 Million Series B Financing to Accelerate the Roll-Out of its SmartLab of the... New financing will expand the next generation of smart lab solutions with direct access to automation to accelerate discovery in the life sciences https://www.biospace.com/esprit-pharma-inc-successfully-completes-series-b-financing-raising-in-excess-of-90m Esprit Pharma, Inc. Successfully Completes Series B Financing, Raising In Excess Of $90M - BioSpace https://www.businesswire.com/news/home/20221011005203/en/Neumora-Therapeutics-Announces-%24112-Million-Series-B-Financing Neumora Therapeutics Announces $112 Million Series B Financing Neumora Therapeutics, Inc. (Neumora), a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of dat... 112 millionseries btherapeuticsannouncesfinancing